SEC Form 13F
Exor N.V. 13F holdings
Quarter ended Sep 30, 2026, filed with the SEC on Nov 13, 2026. Largest holding: RACE at 55.8%.



- Reported value
- $26.60B
- Holdings
- 7
- Top 10 holdings
- 100.0%
- of the reported 13F total
- Changes since —
- No comparable prior filing
Top holdings
The 7 largest of 7 positions by weight. Option rows are not included.
| # | Company | Weight | Change vs prior quarter |
|---|---|---|---|
| 1 | RACE FERRARI N V | 55.79% | — |
| 2 | CNH CNH INDL N V | 17.73% | — |
| 3 | KONINKLIJKE PHILIPS N V | 17.08% | — |
| 4 | STLA STELLANTIS N.V | 7.37% | — |
| 5 | VIA VIA TRANSN INC | 1.61% | — |
| 6 | CLVT CLARIVATE PLC | 0.42% | — |
| 7 | NMRA NEUMORA THERAPEUTICS INC. | 0.01% | — |
Follow Exor N.V. without refreshing SEC filings
TopOne tracks every new 13F, Congress trade and insider filing, shows what changed, and lets you research any holding with AI. Free to start.
Track Exor N.V. in TopOneAbout this data
Positions as reported in the SEC Form 13F-HR filing, valued at quarter-end prices. Weights are each position's share of the reported 13F total, not of the manager's total assets, and say nothing about returns.
A 13F shows US-listed long positions on the last day of the quarter and is filed up to 45 days later. Short positions, cash, bonds and most non-US holdings are not included, and positions may have changed since.
Source: SEC Form 13F-HR, accession 0001193125-26-459439.
Information only. Not investment advice or a recommendation to buy or sell any security.